Abingworth’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Abingworth’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-62,500	Closed	-$2.87M	–	19
2015 Q1	$2.87M	Hold	62,500	–	–	1.22%	12
2014 Q4	$1.5M	Hold	62,500	–	–	0.43%	13
2014 Q3	$1.58M	Hold	62,500	–	–	0.94%	11
2014 Q2	$1.63M	Hold	62,500	–	–	0.76%	10
2014 Q1	$1.61M	Hold	62,500	–	–	0.89%	11
2013 Q4	$1.26M	Hold	62,500	–	–	0.95%	10
2013 Q3	$1.63M	Hold	62,500	–	–	0.93%	10
2013 Q2	$1.38M	Buy	+62,500	New	+$1.37M	1.06%	9

Abingworth's HPTX Position: Q2 2015 in Review

Abingworth sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 62,500 shares — an estimated $2.87M sold.

Abingworth first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $2.87M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Abingworth reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Abingworth sold 62,500 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $2.87M.
Abingworth first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
Abingworth's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $2.87M in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Abingworth's 13F filing for Q2 2015, filed 14 Aug 2015.